GeneBio Systems
Recombinant Fetuin-A/AHSG Monoclonal Antibody
Recombinant Fetuin-A/AHSG Monoclonal Antibody
SKU:AN300475P
Couldn't load pickup availability
Size::
Storage:This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.
Shipping:Ice bag
Exp date:12 months
Category ID_II:Primary Antibodies
Category ID_III:Recombinant Antibodies;Monoclonal Antibodies
Abbreviation:AHSG
Target Synonym:KUB;SGP;TRPM;NA1/NA;A2HS;AHS;alpha-2-HS-glycoprotein;APOJ;APO-J;CLI;Countertrypin;Fetuin-A;HSGA;KUB1;NA1/NA2;SGP2;SP-40;TRPM2;Fetua;Ahsg
Research Areas:
Conjugation:Unconjugated
Host:Rabbit
Species reactivity:Mouse
Application:IHC-P
Isotype:IgG
Clonality:Monoclonal
Clone NO.:4D9
UNIProt ID:P29699
Accession:
Background:Fetuin-A, also known as Alpha-2-HS-Glycoprotein (AHSG), belongs to the Fetuin family, is a plasma binding protein, and is more abundant in fetal than adult blood. It is involved in several functions, such as endocytosis, brain development and the formation of bone tissue. Fetuins are carrier proteins like albumin. Fetuin-A forms soluble complexes with calcium and phosphate and thus is a carrier of otherwise insoluble calcium phosphate. Thus Fetuin-A is a potent inhibitor of pathological calcification. The circulating levels of fetuin-A, a well-described inhibitor of calcification, regulate the cell-dependent process of osteogenesis. The low circulating fetuin-A levels are associated with a greater prevalence and/or severity of Vascular calcification (VC) and increased risk for all-cause and cardiovascular mortality. However, high circulating fetuin-A levels appear to induce insulin resistance and, in non-dialyzed subjects with diabetic nephropathy, are directly related to VC burden. The emerging role of fetuin-A deficiency as a risk factor in dialysis patients was documented in cross-sectional studies demonstrating a significant correlation with all-cause and cardiovascular mortality. Additionally, Human fetuin-A is a negative acute phase protein involved in inflammatory diseases, thus being a potential physiological regulator of meprin activity. Fetuin-A is a broad-range protease inhibitor. Fetuin-A and cystatin C as endogenous proteolytic regulators of meprin activity broadens our understanding of the proteolytic network in plasma.
Concentration:1 mg/mL
Immunogen:Recombinant Mouse Fetuin-A/AHSG protein
Buffer:0.2 μm filtered solution in PBS
Purification method:Protein A
Dilution:IHC-P 1:100-1:500
Calculated MW:
ObservedMW:
